Abstract:DNA damage can lead to mutations that can alter the function of oncogenes or tumor suppressor genes, thus promoting the development of cancer. p53 plays a multifaceted and complex role in the DNA damage response and cancer progression and is known as the 'guardian of the gene'. When DNA damage occurs, p53 is activated through a series of post-translational modifications, which stabilize the protein and enhance its function as a transcription factor. It regulates processes including cell cycle checkpoints, DNA repair and apoptosis, thereby preventing the spread of damaged DNA and maintaining genome integrity. On the one hand, p53 can initiate cell cycle arrest and induce cells to enter the G1/S and G2/M checkpoints, preventing cells with damaged DNA from continuing to proliferate and gaining time for DNA repair. At the same time, p53 can promote the activation of DNA repair pathways, including base excision repair, nucleotide excision repair and other repair pathways, to ensure the integrity of genetic material. If the damage is too severe to repair, p53 will trigger the apoptosis process to eliminate potential cancer risks in time. p53 also plays a pivotal role in cancer progression. Mutations in the p53 gene are frequently found in many cancers, and the mutated p53 not only loses its normal tumor suppressor function but may even acquire pro-cancer activity. Therefore, we also discuss therapeutic strategies targeting the p53 pathway, such as the use of small-molecule drugs to restore the function of wild-type p53, the inhibition of negative regulatory factors and synthetic lethality approaches for p53-deficient tumors. This review therefore highlights the important role of p53 in maintaining genomic stability and its potential in therapeutic strategies for cancer.

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

PDCD5 Interacts with P53 and Functions As a Positive Regulator in the P53 Pathway.

Δ113p53/Δ133p53 Converts P53 from a Repressor to a Promoter of DNA Double-Stand Break Repair.

Pdcd5-Regulated Cell Fate Decision after Ultraviolet-Irradiation-Induced Dna Damage

JMJD5 Interacts with P53 and Negatively Regulates P53 Function in Control of Cell Cycle and Proliferation.

Cellular functions of programmed cell death 5.

PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Coordination of the Nuclear and Cytoplasmic Activities of P53 in Response to DNA Damage

PDCD5 (programmed Cell Death 5)

Two-phase Dynamics of P53 in the DNA Damage Response

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Coordination Between P21 and DDB2 in the Cellular Response to UV Radiation.

The Combination Of Pulsatile And Switch-Like Behaviors Of P53 In Response To Dna Damage

Cell Fate Decision Mediated by P53 Pulses

Cell Fate Decision by an Adaptable Molecular Timer of P53

Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells

Regulation of the DNA damage response by p53 cofactors.

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

DNA Damage Strength Modulates a Bimodal Switch of P53 Dynamics for Cell-Fate Control